Investigator Sponsored Studies, grants and sponsorships
Vertex Pharmaceuticals offers grants for independent research and education advancing scientific knowledge and care in cystic fibrosis and other Vertex focus diseases.
Funder: Vertex Pharmaceuticals
Due Dates: Rolling (most grants, ISS for CF, Pain, IgAN, education, advocacy, sponsorships) | 2026 (next cycle for Circle of Care, RIA, and VIA awards)
Funding Amounts: No strict cap for most grants; typical awards: up to $750,000 over 3 years (CF Independent RIA, VIA), up to $125,000 over 2 years (CF Mentored RIA); sponsorships/grants sized to fair market value and may not exceed 30% of an organization’s annual budget
Summary: Supports independent research, education, and sponsorships advancing care and knowledge for cystic fibrosis and other Vertex focus diseases.
Key Information: Rolling submission for most programs; RFP/cycles for some disease areas; strict alignment with Vertex's research interests required.
Description
Vertex Pharmaceuticals offers a broad portfolio of funding opportunities to support independent research, medical and patient education, organizational sponsorships, and community initiatives. Their programs are designed to advance scientific knowledge and patient care in cystic fibrosis and other diseases aligned with Vertex’s research priorities, such as sickle cell disease, beta thalassemia, pain, IgA nephropathy, and select rare diseases. Funding is available for investigator-sponsored studies (ISS), medical education, advocacy initiatives, and sponsorships for meetings, events, and organizational memberships.
Vertex emphasizes support for proposals that are scientifically rigorous, non-duplicative, and clearly aligned with their therapeutic interests. Funding is provided directly to organizations (not individuals), and there are both rolling and cycle-based opportunities, depending on the disease area and program type.
